With 13 million new cases worldwide every year, prostate cancer is as a very real public health concern. Prostate cancer is common in over-50s men and the sixth-leading cause of cancer-related death in men worldwide. Like all cancers, prostate cancer is multifactorial鈥搕here are non-...
aMonitoring with PSA after treatment for prostate cancer is a mainstay of clinical practice, although the clinical utility of PSA is variable and depends on the disease stage of the indi-vidual patient. As has recently been observed, the lack of high quality information and paucity of clinical...
Prostate cancer survivorship was the focus of research in all studies. This is a very sizable group, not just in the UK but through the world. This systematic review highlighted the following key components of Survivorship Care with erectile dysfunction, acute and chronic medical co-morbidity and...
Prostate cancer ranks high in the incidence rate of male malignant tumors in our country. The onset age is at a low level before 55 years old, and gradually rises after 55 years old. The incidence rate increases with age, with the peak age being 70-80 years old. The median age of new...
Prostate-specific antigen (PSA) for prostate cancer Radiographic tests such as X-ray and ultrasonography, magnetic resonance imaging, and bone scanning are also performed. What is the treatment for primary lymphoma of bone? Radiation therapy is often combined with chemotherapy. Chemotherapies used incl...
PC pancreatic cancer; GC gastric cancer; GBM glioblastoma; PCa prostate cancer; BRC breast cancer; OC ovarian cancer; ESCC esophageal squamous cell carcinoma; NSCLC non-small cell lung cancer; LUAD Lung adenocarcinoma; LUSC lung squamous cell carcinoma; OS osteosarcoma; RCC renal cell carcinoma; ...
sion.13Asimilarclinicaldilemmaisseeninthescreeningandcancerprognosis.Notsurprisingly,wealsoshowedthat anddiagnosisofprostatecancer.Withtheadventofwithincreasingcancersize,patientstendtomore prostate-specificcreening,thelifetimeincidencecommonlydetectthePTCsthemselves. ofprostatecancerhasrisenfrom1in11to1in6inUnited...
The incidence of prostate cancer in Iran: a systematic review and meta-analysis. Prostate Int. 2018;6(2):41–5. Article PubMed Google Scholar Hassanipour S, Namvar G, Fathalipour M, Salehiniya H. The incidence of kidney cancer in Iran: a systematic review and meta-analysis. ...
We developed a model system of advanced prostate cancer that has acquired resistance to ICB therapy. The PD-1 resistant sublines showed strong downregulation of the mouse major histocompatibility complex (MHC-I), which was reversed by treating cells with either the pan-histone deacetylase (HDAC) ...
Some surgeries for colorectal cancer Radiation to the prostate Surgery for benign prostatic enlargement Multiple sclerosis (a neurological disease with the potential to cause widespread damage to nerves) Long-term diabetes mellitus BPH: Benign enlargement of the prostate is associated with erectile dysfunct...